Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
VASC's Cash to Debt is ranked higher than
85% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.78 vs. VASC: No Debt )
VASC' s 10-Year Cash to Debt Range
Min: 1.53   Max: No Debt
Current: No Debt

Equity to Asset 0.89
VASC's Equity to Asset is ranked higher than
96% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. VASC: 0.89 )
VASC' s 10-Year Equity to Asset Range
Min: 0.41   Max: 0.96
Current: 0.89

0.41
0.96
Interest Coverage 1238.23
VASC's Interest Coverage is ranked higher than
83% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. VASC: 1238.23 )
VASC' s 10-Year Interest Coverage Range
Min: 48.63   Max: 9999.99
Current: 1238.23

48.63
9999.99
F-Score: 5
Z-Score: 22.84
M-Score: -2.84
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 14.57
VASC's Operating margin (%) is ranked higher than
83% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.96 vs. VASC: 14.57 )
VASC' s 10-Year Operating margin (%) Range
Min: -1096.15   Max: 17.33
Current: 14.57

-1096.15
17.33
Net-margin (%) 10.08
VASC's Net-margin (%) is ranked higher than
80% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. VASC: 10.08 )
VASC' s 10-Year Net-margin (%) Range
Min: -1040.69   Max: 27.25
Current: 10.08

-1040.69
27.25
ROE (%) 11.56
VASC's ROE (%) is ranked higher than
81% of the 279 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. VASC: 11.56 )
VASC' s 10-Year ROE (%) Range
Min: -88.56   Max: 50.82
Current: 11.56

-88.56
50.82
ROA (%) 10.30
VASC's ROA (%) is ranked higher than
89% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. VASC: 10.30 )
VASC' s 10-Year ROA (%) Range
Min: -74.11   Max: 36.61
Current: 10.3

-74.11
36.61
ROC (Joel Greenblatt) (%) 38.55
VASC's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. VASC: 38.55 )
VASC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1202.04   Max: 51.05
Current: 38.55

-1202.04
51.05
Revenue Growth (%) 12.10
VASC's Revenue Growth (%) is ranked higher than
85% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. VASC: 12.10 )
VASC' s 10-Year Revenue Growth (%) Range
Min: 8.5   Max: 91.3
Current: 12.1

8.5
91.3
EBITDA Growth (%) 9.60
VASC's EBITDA Growth (%) is ranked higher than
78% of the 209 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.50 vs. VASC: 9.60 )
VASC' s 10-Year EBITDA Growth (%) Range
Min: -65.2   Max: 207.2
Current: 9.6

-65.2
207.2
EPS Growth (%) -19.80
VASC's EPS Growth (%) is ranked higher than
57% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.80 vs. VASC: -19.80 )
VASC' s 10-Year EPS Growth (%) Range
Min: -67.2   Max: 22.1
Current: -19.8

-67.2
22.1
» VASC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

VASC Guru Trades in Q1 2013

Jim Simons 145,300 sh (New)
Bill Frels 82,300 sh (New)
Joel Greenblatt Sold Out
Mario Gabelli 317,871 sh (-0.81%)
» More
Q2 2013

VASC Guru Trades in Q2 2013

Chuck Royce 3,600 sh (New)
Jim Simons 196,800 sh (+35.44%)
Mario Gabelli 312,871 sh (-1.57%)
Bill Frels 71,176 sh (-13.52%)
» More
Q3 2013

VASC Guru Trades in Q3 2013

Jim Simons 234,800 sh (+19.31%)
Bill Frels 75,276 sh (+5.76%)
Chuck Royce 3,600 sh (unchged)
Mario Gabelli 306,671 sh (-1.98%)
» More
Q4 2013

VASC Guru Trades in Q4 2013

Chuck Royce 52,000 sh (+1344.44%)
Bill Frels 118,621 sh (+57.58%)
Jim Simons 271,100 sh (+15.46%)
Mario Gabelli 301,171 sh (-1.79%)
» More
» Details

Insider Trades

Latest Guru Trades with VASC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Sold Out 0.01%$14.4 - $16.71 $ 22.9247%0
Joel Greenblatt 2012-12-31 New Buy0.01%$13.32 - $15.35 $ 22.9257%10137
Mario Gabelli 2011-03-31 Reduce -32.85%0.01%$10.48 - $12.06 $ 22.92108%397196
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.70
VASC's P/E(ttm) is ranked higher than
50% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.30 vs. VASC: 34.70 )
VASC' s 10-Year P/E(ttm) Range
Min: 5.15   Max: 688.46
Current: 34.7

5.15
688.46
P/B 4.10
VASC's P/B is ranked higher than
50% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. VASC: 4.10 )
VASC' s 10-Year P/B Range
Min: 1.14   Max: 17.18
Current: 4.1

1.14
17.18
P/S 3.50
VASC's P/S is ranked lower than
55% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. VASC: 3.50 )
VASC' s 10-Year P/S Range
Min: 1.37   Max: 12.36
Current: 3.5

1.37
12.36
PFCF 25.70
VASC's PFCF is ranked higher than
67% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. VASC: 25.70 )
VASC' s 10-Year PFCF Range
Min: 10.72   Max: 53.46
Current: 25.7

10.72
53.46
EV-to-EBIT 22.70
VASC's EV-to-EBIT is ranked higher than
51% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.39 vs. VASC: 22.70 )
VASC' s 10-Year EV-to-EBIT Range
Min: 9.7   Max: 387
Current: 22.7

9.7
387
PEG 1.90
VASC's PEG is ranked higher than
74% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.25 vs. VASC: 1.90 )
VASC' s 10-Year PEG Range
Min: 0.57   Max: 1.9
Current: 1.9

0.57
1.9
Shiller P/E 29.20
VASC's Shiller P/E is ranked higher than
59% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. VASC: 29.20 )
VASC' s 10-Year Shiller P/E Range
Min: 19.15   Max: 149.17
Current: 29.2

19.15
149.17

Valuation & Return

vs
industry
vs
history
Price/Net Cash 20.50
VASC's Price/Net Cash is ranked lower than
56% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.40 vs. VASC: 20.50 )
VASC' s 10-Year Price/Net Cash Range
Min: 0.89   Max: 526.67
Current: 20.5

0.89
526.67
Price/Net Current Asset Value 10.60
VASC's Price/Net Current Asset Value is ranked higher than
62% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.40 vs. VASC: 10.60 )
VASC' s 10-Year Price/Net Current Asset Value Range
Min: 0.78   Max: 29.1
Current: 10.6

0.78
29.1
Price/Tangible Book 5.30
VASC's Price/Tangible Book is ranked higher than
50% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. VASC: 5.30 )
VASC' s 10-Year Price/Tangible Book Range
Min: 0.68   Max: 10.77
Current: 5.3

0.68
10.77
Price/DCF (Projected) 2.20
VASC's Price/DCF (Projected) is ranked lower than
53% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. VASC: 2.20 )
VASC' s 10-Year Price/DCF (Projected) Range
Min: 1.59   Max: 4.46
Current: 2.2

1.59
4.46
Price/Median PS Value 1.30
VASC's Price/Median PS Value is ranked lower than
52% of the 264 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. VASC: 1.30 )
VASC' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 4.31
Current: 1.3

0.42
4.31
Price/Peter Lynch Fair Value 1.50
VASC's Price/Peter Lynch Fair Value is ranked higher than
81% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. VASC: 1.50 )
VASC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.35   Max: 1.62
Current: 1.5

0.35
1.62
Price/Graham Number 2.90
VASC's Price/Graham Number is ranked lower than
55% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. VASC: 2.90 )
VASC' s 10-Year Price/Graham Number Range
Min: 1.25   Max: 2.89
Current: 2.9

1.25
2.89
Earnings Yield (Greenblatt) 4.40
VASC's Earnings Yield (Greenblatt) is ranked higher than
55% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. VASC: 4.40 )
VASC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 10.3
Current: 4.4

0.3
10.3
Forward Rate of Return (Yacktman) 24.59
VASC's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.47 vs. VASC: 24.59 )
VASC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -10.2   Max: 44.9
Current: 24.59

-10.2
44.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:VA4.Germany
Vascular Solutions, Inc., a Minnesota corporation was incorporated in December 1996, and began operations in February 1997. The Company is a medical device Company, develops products that benefit patients by addressing unmet needs of diagnostic and interventional cardiologists, radiologists and vascular surgeons. As a vertically-integrated medical device company, it generates ideas, create new minimally invasive medical devices, and then deliver these products and related services to physicians through its direct domestic sales force and its international distribution network. Its products and services are divided into three categories: Catheter products, mainly consisting of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions, such as the Pronto extraction catheters used in treating acute myocardial infarction, and also including products used in connection with gaining percutaneous access to the vasculature to perform minimally invasive procedures, such as micro-introducer kits; Hemostat (blood clotting) products, mainly consisting of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets; and Vein products and services, principally consisting of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins. The Company manufactures its products in its facilities located in the suburbs of Minneapolis, Minnesota and in the country of Ireland. The catheter manufacturing and packaging processes occur under a controlled clean room environment. It purchases components from various suppliers and rely on single sources for several parts of its products. It purchases its requirements for thrombin for use in manufacturing products sold in the U.S. under the Thrombin-JMI Supply Agreement with King. Its main competitors include: Medtronic, Abbott Laboratories, Johnson & Johnson, Boston Scientific, Covidien, Merit Medical, Marine Polymer Technologies, Hemcon Medical Technologies, Cook Medical, MedRad, Spectranetics, AngioDynamics, biolitec, Dornier MedTech, St. Jude Medical and Terumo. The Company's products and services are regulated in the United States as medical devices by the FDA under the Federal Food, Drug and Cosmetic Act.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide